CID 25066467

Rebastinib

Structural Information

Molecular Formula
C30H28FN7O3
SMILES
CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
InChI
InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
InChIKey
WVXNSAVVKYZVOE-UHFFFAOYSA-N
Compound name
4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

35
References

3653
Patents

553.22375 Da
Monoisotopic Mass

4.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 554.23103 231.9
[M+Na]+ 576.21297 244.7
[M+NH4]+ 571.25757 234.6
[M+K]+ 592.18691 240.5
[M-H]- 552.21647 237.1
[M+Na-2H]- 574.19842 240.7
[M]+ 553.22320 235.0
[M]- 553.22430 235.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe